Compare ADMA Biologics Inc (ADMA) vs Avient Corporation (AVNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Avient Corporation — how do they compare? ADMA Biologics Inc trades at $9.06 (market cap $2.13B), while Avient Corporation trades at $35.91 (market cap $3.49B). The key difference: Avient Corporation is the larger of the two by market cap, and Avient Corporation pays a 2.89% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | AVNT | |
|---|---|---|
Market Cap | $2.13B | $3.49B |
Sector | Health | Technology |
52-Week High | $20.38 | $43.28 |
52-Week Low | $7.60 | $27.48 |
Enterprise Value | $2.20B | $4.99B |
Dividend Yield | — | 2.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Avient Corporation
Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.
Read more on AVNT →
